Registered entities
APOGEE THERAPEUTICS INC
Reg. No. 880610220United States
Innovation
10 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 760 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 10 |
| 2026 | 2 |
Social engagement
Social engagement: 34.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Deep Track Capital, RTW Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Hiring activity
Hires periodically
15 roles tracked across 4 of the last 12 months
16 May 2026 · Director, Clinical Development – Clinical Science · Remote
6 Apr 2026 · Associate Director, Biostatistics
15 Jan 2026 · Clinical Trial Manager
9 Jan 2026 · Clinical Operations Vendor Manager · Pittsburgh
9 Jan 2026 · Senior Director, Quality Control Analytical Sciences · Milwaukee
Based on job postings tracked across public sources.
Recent activity
28 May 2026
Event
investor conferences with Jefferies and Goldman Sachs
26 May 2026
Event
conference call and webcast on Phase 2 APEX trial of zumilokibart in atopic dermatitis (#eczema)
11 May 2026
Milestone
revenue